Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
In Vitro Drug Dissolution: Alternative Methods01:17

In Vitro Drug Dissolution: Alternative Methods

Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic understanding of LAI suspension intramuscular depot formation: A physicochemical perspective.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

API particle size governs in situ forming implant formation, microstructure evolution and performance.

International journal of pharmaceutics·2026
Same author

Loteprednol etabonate nanostructured lipid carriers for enhanced ocular bioavailability.

Colloids and surfaces. B, Biointerfaces·2026
Same author

Spray freeze drying as a novel strategy to enhance oral delivery of proteins/peptides.

International journal of pharmaceutics·2026
Same author

Impact of macrophages on the dissolution of LAI suspension prodrugs.

International journal of pharmaceutics·2026
Same author

Insights into development of long-acting injectable suspensions.

Journal of controlled release : official journal of the Controlled Release Society·2026

Related Experiment Video

Updated: May 29, 2026

Disposable Dosators Intended for Dry Powder Delivery to Mice
04:59

Disposable Dosators Intended for Dry Powder Delivery to Mice

Published on: August 18, 2023

Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal Consta.

Archana Rawat1, Erika Stippler, Vinod P Shah

  • 1School of Pharmacy, University of Connecticut, 69 North Eagleville Rd, Unit 3092, Storrs, CT 06269, USA. archana.rawat@uconn.edu

International Journal of Pharmaceutics
|September 6, 2011
PubMed
Summary

A new in vitro release testing method for parenteral microspheres was validated using USP apparatus 4. This accelerated method correlates well with real-time testing and is suitable for compendial adaptation.

More Related Videos

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Related Experiment Videos

Last Updated: May 29, 2026

Disposable Dosators Intended for Dry Powder Delivery to Mice
04:59

Disposable Dosators Intended for Dry Powder Delivery to Mice

Published on: August 18, 2023

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems
  • Analytical Chemistry

Background:

  • Controlled release parenteral microspheres require validated in vitro release testing methods.
  • Current methods may lack efficiency or compendial adaptability.
  • Standardized testing is crucial for quality control and regulatory approval.

Purpose of the Study:

  • To validate an in vitro release testing method for controlled release parenteral microspheres.
  • To adapt a USP apparatus 4 method for potential compendial use.
  • To assess the correlation between accelerated and real-time release profiles.

Main Methods:

  • Validation of a USP apparatus 4 method using commercial microspheres (Risperdal Consta).
  • Conducting accelerated and real-time in vitro release tests.
  • Performing robustness and reproducibility testing under varied conditions.

Main Results:

  • The accelerated method significantly reduced test duration with good correlation to real-time profiles.
  • Method robustness was confirmed; release was not flow rate dependent and unaffected by minor variations.
  • Temperature (± 0.5°C) significantly impacted risperidone-catalyzed PLGA degradation and release.
  • The accelerated method demonstrated reproducibility across different systems and analysts.

Conclusions:

  • The modified USP apparatus 4 method is suitable for in vitro release testing of microspheres.
  • The validated accelerated method offers a time-efficient alternative for quality control.
  • This work supports the potential compendial adaptation of the method for microsphere drug release testing.